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INTRODUCTION

D
iabetic retinopathy (DR) is the common capillary complication caused by chronic hyperglycemia, and is the most important cause of vision loss and blindness in working-age adults [1] . Pericyte loss is thought to be the earliest pathological manifestation and the key factor of DR development [2] . Diabetic pericyte loss and hyperglycemiainduced apoptosis of retinal capillary endothelial cells lead to the formation of acellular capillary [3] . A large multi-center clinical trial demonstrated that early intensive glycemia control reduces microvascular injury, and the benefits persist for years [4] [5] . However, existing vascular injury caused by previous hyper-glycemic exposure was unable to be reversed by long-term intensive glucose control [6] [7] .
The authors of the Diabetes Control and Complications Trial (DCCT) and Epidemiology of Diabetes Interventions and
Complications (EDIC) study groups proposed a "metabolic memory" hypothesis to explain these findings [8] [9] . Therefore, the ideal therapeutic strategy to reduce the risk of diabetes capillary complications not only include the early aggressive glycemia control, but also together with reverse abnormal metabolism induced by prior hyperglycemia status. Previous studies demonstrated that high glucose induced excessive reactive oxygen species (ROS) levels which mediated the retinal pericyte apoptosis [10] [11] . However, whether the roles of ROS during pericyte loss and metabolic memory after glucose normalization remains elusive. The mitochondrial antioxidant manganese superoxide dismutase (MnSOD) is a mitochondrial antioxidant enzyme, which catalzses superoxide anion radicals to hydrogen peroxides, and protect cells from ROS-mediated injury [12] [13] . Our previous study showed that [14] , in streptozotocin (STZ)-induced diabetic rats, after maintaining at a high glucose level for 6mo, intensive glycemia control failed to ameliorate capillary cell apoptosis and acellular capillaries formation, as well as decreased activities of retinal MnSOD in vivo. Moreover, no reversion of MnSOD activities observed in mouse even after glucose normalization for another 6mo. This lead to the conclusion that as a primary ROS detoxifying enzymes, MnSOD could be a specific symbol to evaluate and predict the severity of metabolic memory. Moreover, it's come up to a hypothesis that will MnSOD overexpression be effective against metabolic memory? Could it be a potential therapeutic strategy of hyperglycemia induced capillary injury? In the present study, we observed the changes of bovine retinal capillary pericytes (BRPs) activities under high glucose exposure in vitro and investigated the roles of ROS in pericytes injury. Then we utilized gene therapy to increase the expression of MnSOD in BRP in vitro, and evaluated their therapeutic efficiency on DR. 
MATERIALS AND METHODS
Ethical Approval
Isolation and Culture of Bovine Retinal Pericytes
Retinal pericytes were isolated from bovine retinal microvesselsas previously described [15] . Briefly, fresh bovine retinas (2 retinae per culture dish) were dissected and homogenized. The homogenate was resuspended in DMEM containing 0.2% collagenase II. After digestion (60min at 37℃), fragments of microvessels were collected on a sieve (100 μm mesh) and seeded on dishes (100 μg per 25 cm 2 diameter dish). BRP cultures were nearly 100% purity as assessed by positive staining for smooth muscle actin (SMA), and negative staining for von Willebr and Factor (vWF) and glial fibrillary acidic protein (GFAP). Primary culture of BRP was grown in 3 mL of DMEM, containing 5.6 mmol/L glucose, supplemented with 20% fetal calf serum, 2 mmol/L glutamine, and antibiotics. The cells at the third and fourth passages were used for experiments. All the results were from at least three independent experiments and each condition includes three dishes. Experimental Groups and Cell Viability Assessment The experimental groups were described in Table 1 . BRPs were grown in indicated media for 8d. Each high-glucose condition is paired with according control condition of equivalent osmotic pressure, which uses media containing 5.6 mmol/L glucose and certain levels of mannitol (14.4, 19.4 , and 24.4 mmol/L, respectively). In metabolic memory experimental groups, BRPs were first cultured in high-glucose medium (20, 25 , and 30 mmol/L) for 2, 4, and 6d respectively, and then grown in Reverse Transcription-Polymerase Chain Reaction Analysis of MnSOD mRNA RNA was extracted from cells using the RNeasy mini kit and reverse transcriptionpolymerase chain reaction (RT-PCR) was carried out using the one step RT-PCR Kit (Applied Biosystems). The following forward and reverse primers were used: MnSOD forward 5'-GCTTACAGATTGCTG CTTGTTC-3'; reverse 5'-GCAGTTACATTCTCCCAGTTGA-3' and β-actin forward 5'-CACGAAACTACCTTCAATTCCA-3'; reverse 5'-GATCTCTTTCTGCATCCTGTCC-3'.
Detection of MnSOD Activity in Bovine Retinal Pericytes
The activity of MnSOD was measured under instructions using the kits from Cayman Chemical (AnnArbor, MI, USA activity was determined by performing the assay in the presence of potassium cyanide to inhibit Cu-ZnSOD, thus measuring the residual MnSOD activity.
Adeno-associated Virus Recombinant MnSOD Preparation and Transfection
The adeno-associated virus recombinant MnSOD (rAAV-MnSOD) was a gift from Dr. Alfred S. Lewin, Department of Ophthalmology, University of Florida, USA. The preparation was previously described in our study [14] .
Briefly, recombinant AAV vector backbone pTR-UF11 was used to accept the MnSOD cDNA. Gene expression was driven by hybrid cytomegalovirus and chicken β-actin proximal promoter. The resultant pTR-MnSOD plasmids were amplified, then purified and packaged as an AAV serotype 2 vector. Each virus preparation contained approximately 10 genome copies/mL [12] . The resultant AAV packaged with humanized green fluorescent protein (GFP) was established as control.
Detection of Reactive Oxygen Species in Bovine Retinal
Pericytes To measure cellular ROS, pericytes were loaded with CM. H2DCFDA and MitoTracker probes (Invitrogen, Eugene, Oregon, USA) separately. ROS and mitochondria were observed by fluorescence microscope, use 488 nm and 543 nm laser for irradiation. Three views were randomly chosen, the average fluorescence intensity was analyzed by Leica Qwin V3 software. Statistical Analysis Statistical analysis was carried out using commercially available GraphPad Prism software (GraphPad Software, Inc., La Jolla, CA, USA). All results are expressed as mean±SEM, and compared by means of one-way ANOVA between several groups or t-test between two independent samples. Differences were considered statistically significant at P<0.05.
RESULTS
BRPs were grown in media containing different concentrations of glucose for 8d. The experimental groups were described in Table 1 . After culture in high glucose for 2d, pericytes already showed signs of cell damage ( Figure 1 ). As shown in Figure 1 , high glucose decreased pericyte viability in a dose-dependent and time-dependent manner. Viability of BRPs cells was gradually reduced in 30 mmol/L hyperglycemia control group (Hy CG) over time compared with normal control group (CG; Figure 1K ). The rates of viability reduction showed positive correlation with glucose concentrations. In 20 Hy-1 ( Figure 1A ) and 25 Hy-1 ( Figure 1D ) groups, cell viabilities were improved on day 4, and totally recovered on day 6 compared with CG group (P>0.05). In 25 Hy-2 ( Figure 1E ) groups, the tendency of viability reduction was reversed on day 6, but failed to totally recovery on day 8 (compared with CG group, P<0.05). At 30 mmol/L glucose concentration, cell injury was severe, and need longer time for recovery. In 30 Hy-1 group (Figure 1G ), cell viability was totally recovered on day 8 (compared with CG group, P>0.05).
Metabolic memory phenomenon was observed in 30 Hy-2 group ( Figure 1H ), after exposed under 30 mmol/L glucose for 4d, cell injury was further increased in the following 4d till the end of observation (compared with CG group, P<0.001).
The cells apoptosis, activity and protein expression of MnSOD and caspase-3 in metabolic memory phenomenon. As shown in Figure 1 , 30 Hy-2 group was selected as a suitable group for investigation of metabolic memory. We then further detected the cells apoptosis and expression of MnSOD on 30 Hy-2 group compared with control groups. ELISA ( Figure 2A ) and Western blot ( Figure 2B, C) showed that BRPs apoptosis and 
05).
To further explore the underlying mechanism of metabolic memory, the expression of MnSOD was assessed by Western blot and RT-PCR. As showed in Figure 3 , expression of MnSOD protein ( Figure 3B, 3C ) and mRNA ( Figure 3A) increased in Hy CG and 30 Hy-2 groups at first 4d compared with normal glucose control group. Meanwhile, damage of MnSOD activity ( Figure 3C ) induced by high glucose environment was continuous increased over time in Hy CG and 30 Hy-2 groups (compared with CG group). Interestingly, at the endpoint of observation, expression of both MnSOD protein and mRNA decreased on day 8 (P<0.01) in high glucose and metabolic memory group compared with CG group (P<0.05), even lower than that in control group which may indicate the compensative mechanism disappeared. To detect intracellular ROS, we used two probes (Molecular Probes, Eugene, OR, USA). The probe DCFDA was used to detect hydrogen peroxide. DCFDA has no fluorescence until it passively diffuses into cells, where an esterase cleaves the acetates, and the oxidation of DCFDA produces a green fluorescent signal. MitoTracker RED FM could penetrate the cytomembrane and exert a red fluorescent signal in live cells. Thus, ROS in living cell was double marked and showed orange signal in mitochondria. The fluorescence intensity significantly increased in Hy CG and 30 Hy-2 groups versus GC group (Figure 3E; P<0.01) . Furthermore, we investigated the effect of rAAV-MnSOD gene therapy on reversing metabolic memory phenomenon. As shown in Figure 3B and 3C, 4d after BRPs infected with rAAV-MnSOD, the expression of MnSOD increased compared to cells treated with AAV-GFP (P<0.001), and such increase lasted till eight days post infection. As demonstrated in Figure  3A , a similar effect was seen at the MnSOD activity compared with CG group. Meanwhile, in a protein level even reached the two-fold level versus normal control on day 8 (Figure 3) , whereas AAV-GFP did not showed any influence on expression. What's important, the increasing of intracellular ROS was attenuated by pretreatment with the rAAV-MnSOD (Figure 4 ) compare with 30Hy-2 metabolic memory groups (P<0.05). Under the same situation, apoptosis and activated caspase-3 of preprocessed BRPs by rAAV-MnSOD significantly decreased (compared with Hy CG and 30 Hy-2 metabolic memory groups; Figure 2) . DISCUSSION In the clinical course of DR, "metabolic memory" is a famous phenomenon, which indicates the long-term effect of poor prior glycemic control on diabetic complications [8] [9] 16] .
ROS in bovine retinal pericytes
This hypothesis has been supported by several large scales randomized clinical studies, while the exact mechanism remains elusive [17] . To investigate the pathophysiology changes of metabolic memory, we reported that STZ-induced rats after six months of hyperglycemia increased the thickness of capillary basement membranes in the nerve fiber layer and outer plexiform layer, decreased the ratio of pericyte area and cross-sectional area of capillary vessels, increased numbers of acellular capillaries and apoptosis of retinal capillary cells. Pathological changes listed above failing to reverse even after normalization of glucose level [14] . The earliest histopathological feature of DR is pericyte dropout from the retinal capillaries [18] . Similar experimental evidences were found in the kidney and cardiovascular system [19] [20] [21] . Emerging data suggest that the damage following hyperglycemiainduced oxidative stress is persistent for a long duration, and not easily reversed under metabolic memory situation [22] [23] . In order to seek a potential strategy to reverse this phenomenon, we imitated a model of metabolic memory in vitro. In our exvivo metabolic memory model, where the normal level of glucose was initiated soon after the hyperglycemia, BRPs viability remain decreasing, while cell apoptosis and activated caspase-3 expression increased over time, which indicated the model can represent metabolic memory for further investigation.
To date, four mechanisms have been regarded to play key roles in metabolic memory: oxidative stress, advanced glycation end products (AGEs), epigenetic changes, and chronic inflammation [24] [25] [26] . As reported, in the early stage of the hyperglycemia, increased oxidative stress, and excessive AGEs formation leading to a persistent damage in mitochondria. A linear relationship between AGEs accumulation and epigenetic changes, and the latter resulting DNA sequence and phenotypic changes. In this study, overproducing of intracellular ROS, the most common free radicals that contain oxygen, indicated the imbalance between the oxidative stress and antioxidant capacity. ROS are produced in mitochondria, which suggests that mitochondrial response plays an important role in hyperglycemia-induced tissue damage [24] [25] [26] . MnSOD is a mitochondrial superoxide scavenging enzyme which catalyzes the dismutation of superoxide anion (O 2 -) into hydrogen peroxides (H 2 O 2 ) and molecular oxygen (O 2 ) and protects cells from oxidative damage associated with exposure to ROS [18] . Previous studies showed that the decreasing of MnSOD activity was involved in the development of DR and metabolic memory phenomenon [27] [28] [29] [30] . The decreased scavenging enzymes activity and increased oxidative stress are causes of pericyte dropout in DR [31] [32] . In our study, the results showed that continuous high glucose exposure for 4 or 8d significantly elevated the ROS of mitochondria and significantly decreased the activity of MnSOD. However, the mRNA and protein expression of MnSOD was significantly increased for 4d. The increased MnSOD in early stage may be due to accommodating ROS production compensatively to protect BRPs cell from ROS damage [31] . However, with aggravation of ROS damage, the apoptosis of BRPs increased, and then the synthesis of MnSOD may be decreased in late stage and the compensative mechanism disappeared [13] . Previously, we reported that intravitreal injection of rAAVMnSOD dramatically elevated the level and activities of retinal MnSOD in STZ-induced diabetic rats. Intravitreal injection of rAAV-MnSOD effectively increased the ratio of pericyte areas and cross-sectional areas of capillary vessels, preventing formation of acellular capillaries and apoptosis of retinal capillary cells [14] . In this study, we assessed a reverse effect for metabolic memory induced by gene therapy which focused on the expression of ROS and MnSOD, and observed similar effects on BRPs transfect with rAAV-MnSOD in vitro. Our results have demonstrated that BRPs were pretreated with rAAV-MnSOD and subsequently incubated in high glucose (30 mmol/L) for 4d followed by normal glucose (5.6 mmol/L) for 4d, the ROS of mitochondria, expression of caspase-3 and the cell apoptosis were significantly decreased compared with cells which unpretreated with rAAV-MnSOD or incubated in continuous high glucose for 8d. This suggests that the overexpression of MnSOD by rAAV-MnSOD transfection can effectively increase the activity of MnSOD, inhibit ROS production and BRPs apoptosis. Taken together, we have presented in this study a new therapeutic method to decrease BRPs apoptosis and reverse hyperglycemic memory. Our study first builds an ex vivo cell model of metabolic memory by cell exposed in sequence in 30 mmol/L and normal glucose culture system for 4d. Furthermore, we demonstrated that delivery of antioxidant gene MnSOD can decrease BRPs apoptosis and reverse 
